FRFrancisco Javier Ruperti-Repilado

Francisco Javier Ruperti-Repilado

*This is an algorithmically generated author record based on publicly available information.

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Francisco Javier Ruperti-Repilado has a total of 133 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel Tobler

    Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland

    4 shared publications
  • Daniel Tobler

    Division of Cardiology, University Hospital of Basel, University of Basel, Basel, Switzerland

    4 shared publications
  • Harald Gabriel

    Adult Congenital Heart Disease Program, Medical University of Vienna Division of Cardiology, Vienna, Austria

    4 shared publications
  • Judith Bouchardy

    Department of Cardiology and Cardiac Surgery, Lausanne University Hospital, Lausanne, Switzerland

    4 shared publications
  • Markus Schwerzmann

    Center for Congenital Heart Disease, University Hospital Inselspital, University of Bern, Bern, Switzerland

    4 shared publications
  • Matthias Greutmann

    Adult Congenital Heart Disease Program, University Heart Center, University Hospital Zurich, University of Zurich, Zurich, Switzerland

    4 shared publications

Latest Publications

  • Open Access

    Clinical practical advice for anaesthetic management of adults with congenital heart disease undergoing non-cardiac surgery: A clinical consensus statement of the ESC Working Group on Adult Congenital Heart Disease, the European Society of Anaesthesiology and Intensive Care, the European Association of Cardiothoracic Anaesthesiology and Intensive Care and the International Society of Adult Congenital Heart Disease

    by Laura Dos-Subirà, Koen Rijs, Montserrat Ribas-Ball, Margarita Brida, Paul Clift, Gerhard Diller, Michael Gatzoulis, Jane Heggie, Dan Longrois, Sascha Meier, et al.

    Adult congenital heart disease (ACHD) patients often require non-cardiac surgery (NCS) and the need of such interventions is growing as the population ages. The intricacies inherent to their distinct physiology pose ACHD patients at a higher risk of perioperative complications, perioperative mortality, longer length of stay, and higher hospital charges compared with the general population. While 2020 ESC guidelines comprehensively address most aspects of ACHD care, they do not cover this specific area. Furthermore, although risk assessment for non-cardiac surgery is included in the 2022 ESC Guidelines on Cardiovascular Assessment and Management of Patients Undergoing Non-Cardiac Surgery, the unique pathophysiology of ACHD patients necessitates tailored considerations. The aim of this clinical consensus statement is to address the specific situations and needs of ACHD patients undergoing NCS from a multidisciplinary and practical point of view and to describe the organization of care for this complex group of patients. A group of experienced professionals from 4 cardiology and anaesthesiology scientific societies [the ESC Working Group on ACHD, the European Society of Anaesthesiology and Intensive Care (ESAIC), the European Association of Cardiothoracic Anaesthesiology and Intensive Care (EACTAIC), and the International Society of Adult Congenital Heart Disease (ISACHD)] have evaluated the available scientific data and reached expert consensus in areas of gaps in evidence.


  • Open Access

    Feasibility and accuracy of wearable electrocardiogram monitoring in adult congenital heart disease

    by Florine Runge, Jonas Brügger, Francisco Javier Ruperti-Repilado, Behnam Subin, Fabian Jordan, Corinne Isenegger, Christian Sticherling, Michael Kühne, Felix Mahfoud, Daniel Tobler, et al.


  • Open Access

    The importance of regional centres in the management of adults with congenital heart disease in Switzerland: a retrospective, multicentric cohort study

    by Mariella Machaczek, Francisco Javier Ruperti-Repilado, Fabian Tran, Simon F. Stämpfli, Dominik Stambach, Matthias Greutmann, Markus Schwerzmann, Daniel Tobler

    OBJECTIVE: We aimed to assess the extent of cardiac-related hospitalisations among adult congenital heart disease (ACHD) patients followed at Swiss regional ACHD centres. BACKGROUND: In Switzerland, adult congenital heart disease patients are followed at specialised ACHD centres. According to the Swiss recommendations for standards of adult congenital heart disease care,ACHD centres are categorised as regional and supraregional centres. In contrast to regional centres, supraregional centres require staffing for congenital cardiac surgery and complex congenital cardiac interventions. METHODS: Adult congenital heart disease patients enrolled in the SACHER registry and followed at one of three regional ACHD centres (University Hospital Basel, St Gallen Cantonal Hospital, Lucerne Cantonal Hospital) from May 2014 to March 2022 were included. Data were abstracted by chart review and included demographics, clinical and surgical history, follow-up duration and cardiac-related hospitalisations during follow-up. RESULTS: In total, 1031 patients (accounting for 22% of patients from the entire SACHER cohort) were included (570 at University Hospital Basel, 231 at St Gallen Cantonal Hospital, 230 at Lucerne Cantonal Hospital). During a median (IQR) follow-up of 3 (1–5) years, there were 237 hospitalisations (100 [42%] emergencies) among 136 (13%) patients. The majority of admissions (157, 66%), occurred at the regional centre. Arrhythmias (49 of 64 admissions, 77%) and heart failure hospitalisations (26 of 34, 76%) were mainly managed locally. The main reasons for referral to supraregional ACHD centres were heart surgery (32/56, 57%) and complex structural percutaneous interventions (pulmonary valve replacement [3/3, 100%] and balloon dilation of aortic coarctation [7/7, 100%]). CONCLUSION: In Switzerland, regional ACHD centres provide an important contribution to the management of the growing cohort of adult congenital heart disease patients. Most hospitalisations were managed locally. This was particularly true for emergencies, arrhythmia and heart failure hospitalisations. The main reasons for referral to supraregional ACHD centres were complex percutaneous interventions.

  • Open Access

    Aortic coarctation and long-term morbidity after arterial switch operation: a multicentre international cohort study

    by Francisco Javier Ruperti-Repilado, Raquel Ladrón, Pedro Lopez-Ayala, Beshoy Gabra, Victor González-Fernández, Leo J Engele, Begoña Manso, Berto J Bouma, Harald Gabriel, Fabienne Schwitz, et al.

    Background In patients with dextro-transposition of the great arteries, cardiovascular interventions and complications are common after the arterial switch operation (ASO). While complex anatomy—typically defined by ventricular septal defects (VSDs)—is often linked to these outcomes, the independent role of aortic coarctation (CoA) remains unclear. Methods We analysed 502 adults from the EPOCH (European collaboration for Prospective Outcome research in Congenital Heart disease)-ASO multicentre registry (median age 25.5 years). The primary outcome was time to first right ventricular outflow tract (RVOT)-related intervention. Secondary outcomes included left ventricular outflow tract (LVOT)-related interventions and cardiovascular complications. Associations were assessed using adjusted Cox regression and Andersen-Gill models. Results CoA emerged as the strongest independent predictor of RVOT interventions (HR 2.62), LVOT interventions (HR 10.75) and cardiovascular complications (HR 2.16). In contrast, VSD (complex anatomy) showed weaker or no associations. CoA also predicted higher recurrence rates of both RVOT and LVOT interventions. Conclusions Among adults post-ASO, CoA—not VSD—is the dominant anatomical driver of long-term morbidity. These patients require targeted surgical attention and structured, lifelong follow-up to mitigate future complications. Trial registration number NCT04335448.

  • Congesti n venosa en paciente con d-TGA tras Mustard

    by Francisco Javier Ruperti-Repilado, Félix Coserria-Sánchez, Amadeo Wals-Rodríguez, Agustín Guisado, José Díaz-Fernández Y, Pastora Gallego

  • Open Access

    A calcified, eroded, and thrombosed Mustard: recurrent embolic strokes in a patient with dextro-transpostion of the great arteries corrected by atrial switch—case report

    by Francisco Javier Ruperti-Repilado, Amadeo Wals-Rodriguez, Miguel Angel Japon, Antonio Gonzalez-Calle, Pastora Gallego

    Background: After an atrial switch operation, baffle complications such as stenosis and dehiscence are common. While thromboembolic events attributed to baffle leaks are well known, thrombosis at the pulmonary venous baffle as a source of cardioembolic stroke has not been previously reported. Case summary: We describe the case of a 43-year-old Caucasian male with recurrent cardioembolic strokes due to a calcified, broken, and thrombosed baffle with floaty, anticoagulant-resistant thrombi adhered to the side of the pulmonary venous return of Mustard patch. Surgery was the only curative option due to thrombi recurrence under different regimes of anticoagulation. Discussion: A case of recurrent cardioembolic strokes long after Mustard surgery due to thrombi on a heavily calcified pericardial patch is presented. A fracture in the patch led to the exposure of thrombogenic material, which had accumulated around the pacemaker (PM) leads on the systemic venous side of the baffle. This exposure allowed thrombotic material to reach the pulmonary venous side, ultimately entering the subaortic right ventricle and the systemic circulation. In the Mustard procedure, the material used for the baffle construction is prone to degeneration and calcification over time. We hypothesize that chronic mechanical stress from the PM leads might have contributed to the gradual erosion and fracture and consequently thrombosis of the heavily calcified patch, leading to recurrent strokes. Surgery became necessary as aggressive anticoagulation failed to prevent thrombus recurrence.


  • Open Access

    Venous congestion in a d-TGA patient after Mustard procedure

    by Francisco Javier Ruperti-Repilado, Félix Coserria-Sánchez, Amadeo Wals-Rodríguez, Agustín Guisado, José Díaz-Fernández, Pastora Gallego

  • Open Access

    Prognostic Value and Determinants of High‐Sensitivity Cardiac Troponin T in Patients With a Systemic Right Ventricle: Insights From the SERVE Trial

    by Francisco Javier Ruperti‐Repilado, Fabian Tran, Philip Haaf, Pedro Lopez‐Ayala, Matthias Greutmann, Markus Schwerzmann, Judith Bouchardy, Harald Gabriel, Dominik Stambach, Tobias Rutz, et al.

    Background: The determinants and prognostic value of high‐sensitivity cardiac troponin T (hs‐cTnT) among patients with a systemic right ventricle are largely unknown. Methods and Results: Ninety‐eight patients from the randomized controlled SERVE (Effect of Phosphodiesterase‐5 Inhibition With Tadalafil on Systemic Right Ventricular Size and Function) trial were included. The correlation between baseline hs‐cTnT concentrations and biventricular volumes and function quantified by cardiac magnetic resonance or cardiac multirow detector computed tomography was assessed by adjusted linear regression models. The prognostic value of hs‐cTnT was assessed by adjusted Cox proportional hazards models, survival analysis, and concordance statistics. The primary outcome was time to the composite of clinically relevant arrhythmia, hospitalization for heart failure, or all‐cause death. Median age was 39 (interquartile range, 32–48) years, and 32% were women. Median hs‐cTnT concentration was 7 (interquartile range, 4–11) ng/L. Coefficients of determination for the relationship between hs‐cTnT concentrations and right ventricular end‐systolic volume index and right ventricular ejection fraction (RVEF) were +0.368 ( P =0.046) and −0.381 ( P =0.018), respectively. The sex‐ and age‐adjusted hazard ratio for the primary outcome of hs‐cTnT at 2 and 4 times the reference level (5 ng/L) were 2.89 (95% CI, 1.14–7.29) and 4.42 (95% CI, 1.21–16.15), respectively. The prognostic performance quantified by the concordance statistics for age‐ and sex‐adjusted models based on hs‐cTnT, right ventricular ejection fraction, and peak oxygen uptake predicted were comparable: 0.71% (95% CI, 0.61–0.82), 0.72% (95% CI, 0.59–0.84), and 0.71% (95% CI, 0.59–0.83), respectively. Conclusions: Hs‐cTnT concentration was significantly correlated with right ventricular ejection fraction and right ventricular end‐systolic volume index in patients with a systemic right ventricle. The prognostic accuracy of hs‐cTnT was comparable to that of right ventricular ejection fraction and peak oxygen uptake predicted. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03049540.


  • Open Access

    Impact of pulmonary valve replacement on ventricular function and cardiac events in patients with tetralogy of Fallot. A retrospective cohort study

    by Francisco Javier Ruperti-Repilado, Nora Haag, Thomas Fischer, Bruno Santos Lopes, Lukas Meier, Kerstin Wustmann, Francesca Bonassin, Christine Attenhofer Jost, Fabienne Schwitz, Markus Schwerzmann, et al.